Table 2. Correlation between SphK1 expression and clinicopathologic characteristics of ACC patients.
Ovearall (n = 24) |
Sphk1 Staining Low (n = 8) |
High (n = 16) |
P | |
---|---|---|---|---|
Age, y | ||||
≥ 50 | 13 | 4 | 9 | 1.000 |
< 50 | 11 | 4 | 7 | |
Gender | ||||
Female | 14 | 5 | 11 | 1.000 |
Man | 10 | 3 | 5 | |
Side | ||||
Right adrenal | 13 | 3 | 10 | 0.390 |
Left adrenal | 11 | 5 | 6 | |
Tumor size | ||||
≥ 5.0 cm | 17 | 2 | 15 | 0.001 |
< 5.0 cm | 7 | 6 | 1 | |
ENSAT Stage | 0.023 | |||
1 | 5 | 4 | 1 | |
2 | 7 | 3 | 4 | |
3 | 10 | 1 | 9 | |
4 | 2 | 0 | 2 | |
Overall survival median (months) | 17.5 | 34.5 | 14 | 0.03 |